×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
INSTITUTE OF COL... [2]
Faculty of Healt... [1]
Authors
LEUNG LAI HAN [1]
Document Type
Journal article [2]
Date Issued
2022 [2]
Language
英語English [1]
Source Publication
PHARMACOLOGICAL ... [1]
Pharmacological ... [1]
Indexed By
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Down regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Journal article
Xie Ying, Feng SenLing, He Fang, Yan PeiYu, Yao XiaoJun, Fan XingXing, Leung Elaine Lai Han, Zhou Hua. Down regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer[J]. Pharmacological Research, 2022.
Authors:
Xie Ying
;
Feng SenLing
;
He Fang
;
Yan PeiYu
;
Yao XiaoJun
; et al.
Adobe PDF
|
Favorite
|
IF:
9.1
/
9.0
|
Submit date:2023/10/24
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Journal article
Xie Ying, Feng SenLing, He Fang, Yan PeiYu, Yao XiaoJun, Fan XingXing, Leung Elaine Lai Han, Zhou Hua. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer[J]. PHARMACOLOGICAL RESEARCH, 2022, 186, 106514.
Authors:
Xie Ying
;
Feng SenLing
;
He Fang
;
Yan PeiYu
;
Yao XiaoJun
; et al.
Favorite
|
TC[WOS]:
15
TC[Scopus]:
14
IF:
9.1
/
9.0
|
Submit date:2023/01/30
Drug Resistance
Chemotherapy
Egfr Tyrosine Kinase Inhibitors
Nrf2
Tangeretin